🇺🇸 FDA
Patent

US 7855176

Reduced volume formulation of glatiramer acetate and methods of administration

granted A61KA61K38/02A61K38/16

Quick answer

US patent 7855176 (Reduced volume formulation of glatiramer acetate and methods of administration) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/02, A61K38/16, A61K9/0019, A61P